Vienna HIV Infection Via Sex Study
NCT05326061 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 500
Last updated 2022-04-13
Summary
The main objective of this prospective observational cohort study is to investigate the epidemiology, the risk factors and ultimately the incidence of novel HIV infections among individuals at high risk for acquiring HIV via sex practices.
Conditions
- HIV Infections
- HIV Pre-Exposure Prophylaxis
- Sexually Transmitted Diseases
- Gonorrhea
- Chlamydia
- Syphilis
Sponsors & Collaborators
-
Medical University of Vienna
lead OTHER
Eligibility
- Min Age
- 18 Years
- Max Age
- 100 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2020-07-01
- Primary Completion
- 2030-12-31
- Completion
- 2030-12-31
Countries
- Austria
Study Locations
More Related Trials
-
Safety of the HIV Vaccine 732462 in HIV Infected Subjects Aged 18 to 55 Years Old
NCT00814762 ·Status: COMPLETED ·Phase: PHASE1
-
A Study of Patients Who Develop HIV Infection After Enrolling in HIV Vaccine Trials or HIV Vaccine Preparedness Trials
NCT00029913 ·Status: COMPLETED
-
Prevention of Varicella Zoster Virus (VZV)-Reactivation in HIV-positive Individuals Enrolled in a Prospective Immunogenicity and Safety Trial of VZV Vaccine: PROVE-IT-Study
NCT01213810 ·Status: WITHDRAWN ·Phase: PHASE1/PHASE2
-
Study of the Influence of Vaccination in HIV Viral Load and Immunologic Responses Against HIV
NCT00329251 ·Status: COMPLETED ·Phase: PHASE4
-
Screening HIV-Infected Patients for Vaccine Studies
NCT00051519 ·Status: COMPLETED
-
Dose-ranging Study to Evaluate the Safety & Immunogenicity of a HIV Vaccine 732461 in Healthy HIV Seronegative Volunteers
NCT00434512 ·Status: COMPLETED ·Phase: PHASE2
-
Immunogenicity Study of Vacc-4x Versus Placebo in Patients Infected With HIV
NCT00659789 ·Status: COMPLETED ·Phase: PHASE2
-
Safety and Immunogenicity Study of Recombinant Modified Vaccinia Virus Ankara (MVA) Virus to Treat HIV Infection
NCT00386633 ·Status: COMPLETED ·Phase: PHASE1
-
Phase I Study of Vaccination Schedule of Experimental HIV Vaccines
NCT00321061 ·Status: COMPLETED ·Phase: PHASE1
-
Pilot Study Evaluating the Use of Simultaneous HBV, HCV, and HIV Rapid Tests
NCT01790633 ·Status: COMPLETED ·Phase: NA
-
HIV-1 Vaccine Test in Uninfected Adult Volunteers
NCT00047931 ·Status: COMPLETED ·Phase: PHASE1
-
Long-term Follow-up of Participants From Studies Evaluating GSK HIV Vaccine
NCT01092611 ·Status: COMPLETED ·Phase: PHASE1
-
Immune Response of Shingrix Vaccine in People Living With HIV (> 50 y.o.) Compared to Age-matched Controls
NCT05575830 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
The Immunogenicity of Varicella-zoster Virus Vaccine in HIV-infected Children
NCT01138215 ·Status: COMPLETED ·Phase: PHASE4
-
Study of Immunity at the Genital Mucosa of HIV-1 Infected and Healthy Women
NCT01715103 ·Status: TERMINATED ·Phase: NA
-
Phase II Study of AGS-004 as an Immunotherapeutic in Antiretroviral Therapy (ART)-Treated Subjects Infected With HIV
NCT00672191 ·Status: COMPLETED ·Phase: PHASE2
-
Analytical Treatment Interruption (ATI) to Assess the Immune System's Ability to Control HIV in Participants Who Became HIV-infected During the HVTN 703/HPTN 081 AMP Study
NCT04860323 ·Status: COMPLETED ·Phase: NA
-
A HIV Vaccine Trial in Individuals Who Started Antiretrovirals During Primary or Chronic Infection (EHVA T02)
NCT04120415 ·Status: COMPLETED ·Phase: PHASE2
-
Resistance to HIV Infection
NCT00069485 ·Status: UNKNOWN
-
Access HIV Ag/Ab Combo Assay - European Union (EU) Clinical Trial Protocol
NCT04971343 ·Status: COMPLETED
-
Safety of and Immune Response to an HIV-1 DNA Vaccine (VRC HIVDNA009-00-VP) in HIV Uninfected Adults
NCT00071851 ·Status: COMPLETED ·Phase: PHASE1/PHASE2
-
Safety and Therapeutic Efficacy of the VRC01 Antibody in Patients Who Initiated Antiretroviral Therapy During Early Acute HIV Infection
NCT02664415 ·Status: COMPLETED ·Phase: PHASE2
-
Effectiveness of an HIV Vaccine in HIV-Negative Adults in North America Who Are at Risk of HIV Infection
NCT00002441 ·Status: COMPLETED ·Phase: PHASE3
-
Study of HIV-1 Rgp-160 Administered by Mucosal Routes in Healthy Volunteers
NCT00122564 ·Status: TERMINATED ·Phase: PHASE1
-
An HIV Vaccine Preparedness Study
NCT00000915 ·Status: COMPLETED ·Phase: NA